Stocktoria
HARVARD BIOSCIENCE INC HBIO
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2013-10-21
HARVARD BIOSCIENCE INC financials (annual, from 10-K)
| Metric | FY2025 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $86.5M | — | $94.1M | $112.2M | $113.3M |
| Gross profit | $49.9M | — | $54.8M | $66.1M | $60.8M |
| R&D expense | $8.8M | — | $10.4M | $11.8M | $12.3M |
| Operating income | -$48.6M | — | -$6.2M | $1.9M | -$6.9M |
| Income tax | -$686,000 | — | $740,000 | $859,000 | $337,000 |
| Net income | -$56.7M | -$12.4M | -$12.4M | -$3.4M | -$9.5M |
| EPS (diluted) | $-1.28 | — | $-0.28 | $-0.08 | $-0.23 |
| Operating cash flow | $6.7M | — | $1.4M | $14.0M | $1.2M |
| Free cash flow | $5.5M | — | -$1.2M | $12.2M | -$438,000 |
| Cash & equivalents | $8.6M | $6.8M | $4.1M | $4.3M | $4.5M |
| Inventory | $20.8M | $21.6M | $23.2M | $24.7M | $26.4M |
| Total assets | $80.1M | $78.0M | $126.6M | $137.4M | $145.4M |
| Total liabilities | $66.3M | $63.9M | $63.3M | $64.3M | $73.1M |
| Shareholders' equity | $13.7M | $14.1M | $63.3M | $73.1M | $72.2M |
Source: SEC EDGAR filings · CIK 0001123494 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.